Dose banded cytotoxic pharmaceuticals

Dose banded cytotoxic pharmaceuticals

To supply dose banded cytotoxic pharmaceuticals to the West Midlands Pharmacy Alliance participating trusts in the areas served by participating trusts, primarily in Birmingham; University Hospitals Birmingham NHS Foundation Trust & Heart of England Hospital NHS Foundation Trust.

UK-Kings Norton: pharmaceutical products

2012/S 15-023798

Contract notice

Supplies

Directive 2004/18/EC

Section I: Contracting authority

I.1)Name, addresses and contact point(s)

University Hospitals Birmingham
Procurement, University Hospital Birmingham, 32-34 Melchett Road
For the attention of: Mr Rob Johnson
B30 3HG Kings Norton
UNITED KINGDOM
Telephone: +44 7720420343
E-mail: rob.johnson@uhb.nhs.uk

I.2)Type of the contracting authority

Body governed by public law
I.3)Main activity

Health
I.4)Contract award on behalf of other contracting authorities

The contracting authority is purchasing on behalf of other contracting authorities: yes

Section II: Object of the contract

II.1)Description
II.1.1)Title attributed to the contract by the contracting authority:

Dose banded cytotoxic pharmaceuticals.
II.1.2)Type of contract and location of works, place of delivery or of performance

Supplies
Purchase
Main site or location of works, place of delivery or of performance: To supply dose banded cytotoxic pharmaceuticals to the West Midlands Pharmacy Alliance participating trusts in the areas served by participating trusts, primarily in Birmingham; University Hospitals Birmingham NHS Foundation Trust & Heart of England Hospital NHS Foundation Trust.
NUTS code UKG

II.1.3)Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)

The notice involves the establishment of a framework agreement
II.1.4)Information on framework agreement
II.1.5)Short description of the contract or purchase(s)

University Hospitals Birmingham NHS Foundation Trust (lead trust for the West Midlands Pharmacy Alliance) are wishing to tender for the provision of aseptically prepared; batch manufactured anticancer chemotherapy drugs in ready-to-administer presentations in agreed dose bands to be ordered by and delivered in varying quantities to the participating trust(s).
II.1.6)Common procurement vocabulary (CPV)

33600000

II.1.7)Information about Government Procurement Agreement (GPA)

The contract is covered by the Government Procurement Agreement (GPA): yes
II.1.8)Lots

This contract is divided into lots: no
II.1.9)Information about variants
II.2)Quantity or scope of the contract
II.2.1)Total quantity or scope:

To supply dose banded cytotoxic pharmaceuticals to the West Midlands Pharmacy Alliance participating trusts in the areas served by participating trusts, primarily in Birmingham, University Hospitals Birmingham NHS Foundation Trust, Heart of England Hospital NHS Foundation Trust.
The participating trusts will specify points of delivery upon award.
II.2.2)Information about options

Options: no
II.2.3)Information about renewals
II.3)Duration of the contract or time limit for completion

Duration in months: 24 (from the award of the contract)

Section III: Legal, economic, financial and technical information

III.1)Conditions relating to the contract
III.1.1)Deposits and guarantees required:
III.1.2)Main financing conditions and payment arrangements and/or reference to the relevant provisions governing them:
III.1.3)Legal form to be taken by the group of economic operators to whom the contract is to be awarded:
III.1.4)Other particular conditions
III.2)Conditions for participation
III.2.1)Personal situation of economic operators, including requirements relating to enrolment on professional or trade registers

Information and formalities necessary for evaluating if the requirements are met: In accordance with Articles 45 to 50 of Directive 2004/18/EC and Part 4 of the Public Contracts Regulations 2006 and as set out in the pre-qualification questionnaire.
III.2.2)Economic and financial ability

Information and formalities necessary for evaluating if the requirements are met: In accordance with Articles 45 to 50 of Directive 2004/18/EC and Part 4 of the Public Contracts Regulations 2006 and as set out in the pre-qualification questionnaire.
III.2.3)Technical capacity

Information and formalities necessary for evaluating if the requirements are met:
In accordance with Articles 45 to 50 of Directive 2004/18/EC and Part 4 of the Public Contracts Regulations 2006 and as set out in the pre-qualification questionnaire.
III.2.4)Information about reserved contracts
III.3)Conditions specific to services contracts
III.3.1)Information about a particular profession
III.3.2)Staff responsible for the execution of the service

Section IV: Procedure

IV.1)Type of procedure
IV.1.1)Type of procedure

Accelerated restricted
IV.1.2)Limitations on the number of operators who will be invited to tender or to participate

Envisaged minimum number 2: and maximum number 6
IV.1.3)Reduction of the number of operators during the negotiation or dialogue
IV.2)Award criteria
IV.2.1)Award criteria

The most economically advantageous tender in terms of the criteria stated in the specifications, in the invitation to tender or to negotiate or in the descriptive document
IV.2.2)Information about electronic auction

An electronic auction will be used: no
IV.3)Administrative information
IV.3.1)File reference number attributed by the contracting authority:
IV.3.2)Previous publication(s) concerning the same contract
IV.3.3)Conditions for obtaining specifications and additional documents or descriptive document
IV.3.4)Time limit for receipt of tenders or requests to participate

13.2.2012 – 12:00
IV.3.5)Date of dispatch of invitations to tender or to participate to selected candidates
IV.3.6)Language(s) in which tenders or requests to participate may be drawn up

English.
IV.3.7)Minimum time frame during which the tenderer must maintain the tender
IV.3.8)Conditions for opening tenders

Section VI: Complementary information

VI.1)Information about recurrence
VI.2)Information about European Union funds
VI.3)Additional information
VI.4)Procedures for appeal
VI.4.1)Body responsible for appeal procedures
VI.4.2)Lodging of appeals
VI.4.3)Service from which information about the lodging of appeals may be obtained

VI.5)Date of dispatch of this notice:20.1.2012